Cargando…
Application of “omics” to Prion Biomarker Discovery
The advent of genomics and proteomics has been a catalyst for the discovery of biomarkers able to discriminate biological processes such as the pathogenesis of complex diseases. Prompt detection of prion diseases is particularly desirable given their transmissibility, which is responsible for a numb...
Autores principales: | Huzarewich, Rhiannon L. C. H., Siemens, Christine G., Booth, Stephanie A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833310/ https://www.ncbi.nlm.nih.gov/pubmed/20224650 http://dx.doi.org/10.1155/2010/613504 |
Ejemplares similares
-
A miRNA Signature of Prion Induced Neurodegeneration
por: Saba, Reuben, et al.
Publicado: (2008) -
MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State
por: Saba, Reuben, et al.
Publicado: (2012) -
Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies
por: Rhee, June-Wha, et al.
Publicado: (2020) -
Multilevel omics for the discovery of biomarkers in pediatric sepsis
por: Wang, Xinyu, et al.
Publicado: (2023) -
MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications
por: Slota, Jessy A., et al.
Publicado: (2019)